Latest Articles
The effectiveness of stem cell‑derived extracellular vesicles therapy for intrauterine adhesions: a meta-analysis of preclinical studies - Reproductive Biology and Endocrinology
The effectiveness of stem cell‑derived extracellular vesicles therapy for intrauterine adhesions: a meta-analysis of preclinical studies Reproductive Biology and Endocrinology
Published: Aug. 13, 2025, 11:10 a.m.
CD276xCD3 bispecific antibody shows preclinical promise for the treatment of endometrial cancer - BioWorld MedTech
CD276xCD3 bispecific antibody shows preclinical promise for the treatment of endometrial cancer BioWorld MedTech
Published: Aug. 1, 2025, 1 p.m.
Preclinical research models for endometrial cancer: development and selection of animal models - Frontiers
Preclinical research models for endometrial cancer: development and selection of animal models Frontiers
Published: Jan. 17, 2025, 3:02 p.m.
Lisata announces preclinical research agreement to study certepetide with bevacizumab for endometriosis - BioWorld Online
Lisata announces preclinical research agreement to study certepetide with bevacizumab for endometriosis BioWorld Online
Published: Oct. 29, 2024, 1 p.m.
Lisata Therapeutics Announces Sponsored Preclinical - GlobeNewswire
Lisata Therapeutics Announces Sponsored Preclinical GlobeNewswire
Published: Oct. 28, 2024, 2:42 p.m.
Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis - StockTitan
Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis StockTitan
Published: Oct. 28, 2024, 12:30 p.m.
Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - The Manila Times
Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium The Manila Times
Published: Oct. 23, 2024, 10:06 a.m.
Antibody-drug conjugate shows preclinical efficacy - News-Medical.Net
Antibody-drug conjugate shows preclinical efficacy News-Medical.Net
Published: July 13, 2024, 7 a.m.
Link copied to clipboard!